Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

LONDON BROKER RATINGS: Exane raises Spirax, UBS cuts Fermi

Wed, 06th May 2026 09:28

(Alliance News) - The following London-listed shares received analyst recommendations on Wednesday morning and on Tuesday:

----------

FTSE 100

----------

Exane BNP raises Spirax to 'outperform' (neutral) - price target 8,350 (7,500) pence

----------

Keefe Bruyette & Woods raises Standard Chartered to 'market perform'

----------

JPMorgan raises Standard Chartered target to 2,220 (2,200) pence - 'overweight'

----------

Shore Capital raises HSBC to 'hold' (sell)

----------

Goldman Sachs raises HSBC price target to 1,700 (1,650) pence - 'buy'

----------

Jefferies cuts NatWest price target to 730 (750) pence - 'buy'

----------

Jefferies raises Barclays price target to 590 (570) pence - 'buy'

----------

Barclays raises Standard Life price target to 690 (660) pence - 'underweight'

----------

Deutsche Bank Research cuts Whitbread price target to 2,530 (2,815) pence - 'hold'

----------

Citigroup cuts GSK price target to 2,100 (2,250) pence - 'neutral'

----------

Bernstein cuts Informa price target to 1,033 (1,060) pence - 'outperform'

----------

Goldman Sachs raises United Utilities price target to 1,523 (1,346) pence - 'neutral'

----------

Goldman Sachs raises Pearson price target to 1,350 (1,300) pence - 'buy'

----------

Goldman Sachs cuts Mondi price target to 800 (910) pence - 'neutral'

----------

FTSE 250

----------

Deutsche Bank cuts Telecom Plus to 'hold' (buy) - price target 1,300 (2,000) pence

----------

Kepler Cheuvreux starts Primary Health Properties with 'buy' - price target 120 pence

----------

Goldman Sachs cuts Dr Martens price target to 71 (76) pence - 'neutral'

----------

Jefferies cuts Paragon Banking price target to 1,000 (1,060) pence - 'buy'

----------

Jefferies cuts OSB price target to 700 (780) pence - 'buy'

----------

SMALL CAP

----------

UBS cuts Fermi to 'neutral' (buy) - price target 6 (8) USD

----------

Berenberg raises Synthomer price target to 100 (60) pence - 'hold'

----------

Berenberg cuts CLS price target to 58 (80) pence - 'buy'

----------

Comments and questions to newsroom@alliancenews.com

Copyright 2026 Alliance News Ltd. All Rights Reserved.

Broker Recommendations Market News Spirax-Sarco Standard Chartered HSBC Holdings Barclays Natwest Standard Life Whitbread Glaxosmithkline Informa United Utilities Pearson Mondi Telecom Plus Primary Health Dr. Martens Paragon Group OneSavings Bank Fermi Inc CLS Holdings Synthomer

Shares in this article

Related News

LONDON BRIEFING: Next increases profit outlook as sales beat forecast
2 hours ago

LONDON BRIEFING: Next increases profit outlook as sales beat forecast

(Alliance News) - The FTSE 100 was called higher on Wednesday, after US President Donald Trump paused his 'Project Freedom', the military operation to...

Corporate News Next + 8 more shares
EARNINGS AND TRADING: RWS agrees to acquire IP platform Obviously
15 hours ago

EARNINGS AND TRADING: RWS agrees to acquire IP platform Obviously

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately report...

FTSE 100 slides as HSBC's results, inflation fears dent sentiment
16 hours ago

FTSE 100 slides as HSBC's results, inflation fears dent sentiment

May 5 (Reuters) - The UK's ​FTSE 100 ⁠slid more than 1% on Tuesday, ​as traders returned from a bank holiday to witness a rout in financial stocks dri...

Market News HSBC Holdings + 5 more shares